March 21, 2019

BIIB Goes Bye-Bye

Biogen is having a bad day. The investors (the new ones anyway) are feeling the reeling pain of investing into biotech names. This is the truth of reward to risk. When you play in high-beta names as an investor, unfortunately, this can be an outcome. Biogen (Ticker: BIIB) is discontinuing their Alzheimer drug trial. During Phase 3 trial testing, an independent study provided them with little answers and they decided based on the findings they cannot continue the study. What makes this difficult is the pricing of the study was baked into the stock price. Meaning, the stock price is a reflection of future valuations of a company. Since BIIB will not be making any revenue from their Alzheimer drug treatment, traders and investors took profits or took risk off. The second part of this scenario is that BIIB does not have anything that will be a catalyst to the previous pricing of their stock. So now that it is down nearly 30%, there is nothing really to allow the stock to rally back to the higher valuation. This means the stock price is now correcting itself to the current fundamentals and it could mean that BIIB continues lower. This sucks for the investors currently in Biogen. I hope they can recover from this fallout.

about the author:

Charles Moon

Charles Moon is a technical "whiz kid" whose experience lies in scalp/swing trading. A patient educator, Charles excels at coaching/mentoring and can make complex concepts simple. Prior to joining the ranks of Prosper Trading Academy, Charles was a proprietary equities trader with Great Point Capital LLC. Coming from a retail trading background, his experience can help those with no experience trading to seasoned veterans.

Read Similar Articles

September 30, 2020

Bad News For NKLA Can Be Good News For NIO

  We had a great example of a swing buy entry in NIO, Inc., the electric car company (Ticker: NIO). It’s based on a break out pattern on an hourly chart and confirmed with a daily chart.   Click the video below to learn more details: Grab a free day pass to one of our live […]

Read Article
September 29, 2020

The Similarities and Differences Between VIX and VXX

The VIX and VXX are both very popular trading vehicles for trading volatility.  But, unlike the perceptions of many traders, they are not exactly interchangeable.  There are many similarities and more importantly, some very important differences. Click the video below to learn more details: Grab a free day pass to one of our live signal […]

Read Article
August 4, 2020

TSLA Inside Bar Entry

An inside bar is just what the name implied.  It is a bar that is “inside” of another bar.  We use a daily chart for this approach.  So the high from two days ago is higher than the high from one day ago and the low of two days ago is lower than the low […]

Read Article

Read Similar Articles

September 30, 2020

Bad News For NKLA Can Be Good News For NIO

  We had a great example of a swing buy entry in NIO, Inc., the electric car company (Ticker: NIO). It’s based on a break out pattern on an hourly chart and confirmed with a daily chart.   Click the video below to learn more details: Grab a free day pass to one of our live […]

Read Article
September 29, 2020

The Similarities and Differences Between VIX and VXX

The VIX and VXX are both very popular trading vehicles for trading volatility.  But, unlike the perceptions of many traders, they are not exactly interchangeable.  There are many similarities and more importantly, some very important differences. Click the video below to learn more details: Grab a free day pass to one of our live signal […]

Read Article
August 4, 2020

TSLA Inside Bar Entry

An inside bar is just what the name implied.  It is a bar that is “inside” of another bar.  We use a daily chart for this approach.  So the high from two days ago is higher than the high from one day ago and the low of two days ago is lower than the low […]

Read Article